AR038197A1 - Acidos 3-(imidazolil)-2-alcoxipropanoicos, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y uso de los mismos en la preparacion de medicamentos - Google Patents
Acidos 3-(imidazolil)-2-alcoxipropanoicos, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y uso de los mismos en la preparacion de medicamentosInfo
- Publication number
- AR038197A1 AR038197A1 ARP030100165A ARP030100165A AR038197A1 AR 038197 A1 AR038197 A1 AR 038197A1 AR P030100165 A ARP030100165 A AR P030100165A AR P030100165 A ARP030100165 A AR P030100165A AR 038197 A1 AR038197 A1 AR 038197A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- haloalkyl
- halo
- nr13r14
- independently selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto ácido 3-(imidazolil)-2-alcoxipropanoico de acuerdo con la fórmula (1), donde: n es 0, 1, 2 ó 3; R1 se selecciona entre; a) un grupo alquilo C1-6 de cadena lineal o ramificada opcionalmente sustituida: b) un grupo alquenilo C2-6 de cadena lineal o ramificada opcionalmente sustituida, c) un grupo alquinilo C2-6 de cadena lineal o ramificada opcionalmente sustituida, d) arilo, e) heterociclo aromático, f) heterociclo, y g) H; estando los sustituyentes opcionales en los grupos (a), (b) y (c) anteriores seleccionados entre: cicloalquilo C3-7, arilo, heterociclo aromático, heterociclo, OR10, NR10R11, S(O)pR10, OC(O)R11, CO2R10, CONR10R11, SO2NR10R11, halo y NHSO2R10 y siendo p 0, 1, ó 2; cada uno de R2, R3, R4, R6, R7 y R9 se selecciona independientemente entre H y alquilo C1-6 de cadena lineal o ramificada opcionalmente sustituida con OR10 o halo; cada uno de R5 y R8 se seleccionan independientemente entre H y alquilo C1-6 de cadena lineal o ramificada opcionalmente sustituida con OR10 o halo, o tomados conjuntamente son una cadena alquileno C2-6; cada uno de R10 y R11 se selecciona independientemente entre H y alquilo C1-6 de cadena lineal o ramificada; arilo es un grupo monocíclico aromático o carbocíclico policíclico condensado de 6-14 miembros opcionalmente sustituido con uno o más grupos seleccionados entre R12, halo, OR13, NR13R14, NR13CO2R12, CO2R13, NR13SO2R12, CN, haloalquilo, O(haloalquilo), SR13, S(O)R12, SO2R12, OC(O)R13,SO2NR13R14 y C(O)NR13R14, cicloalquilo C3-7, O(cicloalquilo C3-7), R15 y OR15, siendo R12 alquilo C1-6 de cadena lineal o ramificada, seleccionándose cada uno de R13 y R14 independientemente entre H y alquilo C1-6 de cadena lineal o ramificada, y siendo R15 fenilo opcionalmente sustituido con R12, OR13, halo o haloalquilo; heterociclo aromático es un anillo aromático de 5 a 7 miembros que contiene de 1 a 3 heteroátomos, seleccionándose cada uno independientemente entre O, S; y N, estando dicho anillo opcionalmente sustituido con uno o más grupos seleccionados entre OR13, NR13R14, CO2R13, NR13CO2R12, R12, halo, CN, haloalquilo, O(haloalquilo), SR13, S(O)R12, SO2R12, OC(O)R13, NR13SO2R12, SO2NR13R14 y C(O)NR13R14,y heterociclo es un anillo de 3 a 8 miembros que contiene de 1 a 3 heteroátomos, cada uno seleccionado independientemente entre O, S, y N, estando dicho anillo saturado o parcialmente saturado, estando además dicho anillo opcionalmente sustituido con uno o más grupos seleccionados entre OR13, NR13R14, CO2R13,NR13CO2R14, R12, halo, CN, haloalquilo, O(haloalquilo), SR13, S(O)R12, SO2R12, OC(O)R13, NR13SO2R12, SO2NR13R14 y C(O)NR13R14, o un tautómero del mismo o una sal farmacéuticamente aceptable de dicho compuesto o de dicho tautómero. Procedimientos para la preparación de los mismos, composiciones farmacéuticas que los contienen, y uso de los mismos en la preparación de medicamentos útiles para tratar trastornos cardiovasculares.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0201389A GB0201389D0 (en) | 2002-01-22 | 2002-01-22 | 3-(imidazolyl)-2-alkoxypropanoic acids |
| GB0202027A GB0202027D0 (en) | 2002-01-29 | 2002-01-29 | 3-(imidazolyl)-2-alkoxypropanoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038197A1 true AR038197A1 (es) | 2005-01-05 |
Family
ID=27614792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100165A AR038197A1 (es) | 2002-01-22 | 2003-01-21 | Acidos 3-(imidazolil)-2-alcoxipropanoicos, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y uso de los mismos en la preparacion de medicamentos |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1467731A1 (es) |
| JP (1) | JP2005520811A (es) |
| KR (1) | KR20040077775A (es) |
| CN (1) | CN1620291A (es) |
| AP (1) | AP2004003084A0 (es) |
| AR (1) | AR038197A1 (es) |
| BR (1) | BR0307016A (es) |
| CA (1) | CA2472238A1 (es) |
| EA (1) | EA200400716A1 (es) |
| EC (1) | ECSP045200A (es) |
| HR (1) | HRP20040659A2 (es) |
| IL (1) | IL162677A0 (es) |
| IS (1) | IS7310A (es) |
| MA (1) | MA27167A1 (es) |
| MX (1) | MXPA04006573A (es) |
| NO (1) | NO20043457L (es) |
| OA (1) | OA12756A (es) |
| PA (1) | PA8563501A1 (es) |
| PE (1) | PE20030929A1 (es) |
| PL (1) | PL371487A1 (es) |
| TN (1) | TNSN04121A1 (es) |
| TW (1) | TW200302094A (es) |
| UY (1) | UY27615A1 (es) |
| WO (1) | WO2003061652A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005051384A1 (en) * | 2003-11-25 | 2005-06-09 | Pfizer Limited | Stabilised pharmaceutical compositions |
| WO2006113247A1 (en) * | 2005-04-18 | 2006-10-26 | Bayer Schering Pharma Aktiengesellschaft | Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
| CA2741783A1 (en) | 2008-10-29 | 2010-05-06 | Taisho Pharmaceutical Co., Ltd. | Compounds having tafia inhibitory activity |
| TW201033184A (en) * | 2008-12-05 | 2010-09-16 | Mochida Pharm Co Ltd | Morpholinone compounds as factor IXa inhibitors |
| US8987242B2 (en) | 2008-12-05 | 2015-03-24 | Merck Sharp & Dohme Corp. | Morpholinone compounds as factor IXA inhibitors |
| CN105801489B (zh) * | 2010-03-18 | 2019-12-10 | 第一三共株式会社 | 环烷基取代的咪唑衍生物 |
| JP5778133B2 (ja) * | 2010-03-18 | 2015-09-16 | 第一三共株式会社 | シクロプロパンカルボン酸誘導体 |
| AU2014280329A1 (en) | 2013-06-10 | 2016-01-07 | Sanofi | Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals |
| KR20180123038A (ko) | 2016-03-29 | 2018-11-14 | 다이이찌 산쿄 가부시키가이샤 | 염증성 장질환 치료제 |
| JP7158393B2 (ja) | 2017-09-14 | 2022-10-21 | 第一三共株式会社 | 環状構造を有する化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901572D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| WO2002014285A1 (en) * | 2000-08-17 | 2002-02-21 | Pfizer Limited | Substituted imidazoles as tafia inhibitors |
-
2003
- 2003-01-10 KR KR10-2004-7011370A patent/KR20040077775A/ko not_active Application Discontinuation
- 2003-01-10 IL IL16267703A patent/IL162677A0/xx unknown
- 2003-01-10 AP APAP/P/2004/003084A patent/AP2004003084A0/en unknown
- 2003-01-10 JP JP2003561596A patent/JP2005520811A/ja active Pending
- 2003-01-10 BR BR0307016-6A patent/BR0307016A/pt not_active IP Right Cessation
- 2003-01-10 OA OA1200400190A patent/OA12756A/en unknown
- 2003-01-10 MX MXPA04006573A patent/MXPA04006573A/es unknown
- 2003-01-10 WO PCT/IB2003/000060 patent/WO2003061652A1/en not_active Application Discontinuation
- 2003-01-10 PL PL03371487A patent/PL371487A1/xx unknown
- 2003-01-10 EA EA200400716A patent/EA200400716A1/ru unknown
- 2003-01-10 CA CA002472238A patent/CA2472238A1/en not_active Abandoned
- 2003-01-10 EP EP03700059A patent/EP1467731A1/en not_active Withdrawn
- 2003-01-10 CN CNA03802599XA patent/CN1620291A/zh active Pending
- 2003-01-16 TW TW092100889A patent/TW200302094A/zh unknown
- 2003-01-17 PE PE2003000058A patent/PE20030929A1/es not_active Application Discontinuation
- 2003-01-20 UY UY27615A patent/UY27615A1/es not_active Application Discontinuation
- 2003-01-21 AR ARP030100165A patent/AR038197A1/es unknown
- 2003-01-22 PA PA20038563501A patent/PA8563501A1/es unknown
-
2004
- 2004-06-14 IS IS7310A patent/IS7310A/is unknown
- 2004-06-30 TN TNP2004000121A patent/TNSN04121A1/en unknown
- 2004-07-15 MA MA27786A patent/MA27167A1/fr unknown
- 2004-07-19 HR HR20040659A patent/HRP20040659A2/hr not_active Application Discontinuation
- 2004-07-22 EC EC2004005200A patent/ECSP045200A/es unknown
- 2004-08-19 NO NO20043457A patent/NO20043457L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL162677A0 (en) | 2005-11-20 |
| EA200400716A1 (ru) | 2004-12-30 |
| PA8563501A1 (es) | 2004-08-31 |
| PE20030929A1 (es) | 2003-11-05 |
| NO20043457L (no) | 2004-08-19 |
| JP2005520811A (ja) | 2005-07-14 |
| MA27167A1 (fr) | 2005-01-03 |
| MXPA04006573A (es) | 2004-10-04 |
| AP2004003084A0 (en) | 2004-09-30 |
| ECSP045200A (es) | 2004-08-27 |
| OA12756A (en) | 2006-07-03 |
| KR20040077775A (ko) | 2004-09-06 |
| WO2003061652A1 (en) | 2003-07-31 |
| BR0307016A (pt) | 2004-11-03 |
| IS7310A (is) | 2004-06-14 |
| EP1467731A1 (en) | 2004-10-20 |
| CA2472238A1 (en) | 2003-07-31 |
| WO2003061652A8 (en) | 2004-09-10 |
| UY27615A1 (es) | 2003-08-29 |
| TNSN04121A1 (en) | 2006-06-01 |
| CN1620291A (zh) | 2005-05-25 |
| PL371487A1 (en) | 2005-06-13 |
| TW200302094A (en) | 2003-08-01 |
| HRP20040659A2 (en) | 2004-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032781A1 (es) | Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen | |
| AR016523A1 (es) | Compuestos de indol como agentes anti-inflamatorios/analgesicos, composiciones farmaceuticas que los contienen y procedimiento de tratamiento | |
| CO5690588A2 (es) | Derivados de 4-tetrazolilo-4 fenilpiperidina para el trata- miento del dolor | |
| AR033408A1 (es) | Compuestos de bisarilo que contienen nitrogeno orto, orto-sustituidos, procedimientos para su preparacion, su utilizacion para la preparacion de un medicamento como tambien composiciones farmaceuticas que los contienen | |
| NO20053460L (no) | Nye forbindelser med selektiv inhibiterende effekt ved GSK3 | |
| AR045255A1 (es) | Derivados de 1,2 benzodiazol | |
| AR042658A1 (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides | |
| AR038044A1 (es) | Compuesto derivado de pirazina, composicion farmaceutica, su uso en la fabricacion de un medicamento, proceso para su preparacion y compuesto intermediario en dicho proceso. | |
| MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| AR058546A1 (es) | Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1 | |
| MXPA02002720A (es) | Nuevos compuestos de alfa-aminoacido-sulfonilo, un proceso para su preparacion y composiciones farmaceuticas que los comprenden. | |
| ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
| AR036045A1 (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, su empleo para la preparacion de un medicamento, asi como composiciones farmaceuticas que las contienen | |
| EA200900279A1 (ru) | Арилсульфонамиды с аналгетическим действием | |
| AR038197A1 (es) | Acidos 3-(imidazolil)-2-alcoxipropanoicos, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y uso de los mismos en la preparacion de medicamentos | |
| UY25332A1 (es) | Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgésicos | |
| AR043959A1 (es) | Derivados de indolona-acetamida, procesos para prepararlos, composiciones farmaceuticas que los contienen y su uso como productos farmaceuticos | |
| AR050260A1 (es) | Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion | |
| AR044830A1 (es) | Derivados de 4,5 diaril -3-heterociclilpirazin- 2- ester | |
| AR057525A1 (es) | Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion | |
| AR017256A1 (es) | Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden | |
| PE20011183A1 (es) | Metabolitos agonistas/antagonistas de estrogeno | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| PE20020426A1 (es) | ß-TIO-a-AMINOACIDOS, PROCEDIMIENTOS PARA SU PREPARACION Y MEDICAMENTOS QUE LOS CONTIENEN | |
| AR029001A1 (es) | Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |